Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more
Kimia Farma Persero Tbk (KAEF) - Total Assets
Latest total assets as of June 2025: Rp14.97 Trillion IDR
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) holds total assets worth Rp14.97 Trillion IDR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kimia Farma Persero Tbk - Total Assets Trend (2002–2024)
This chart illustrates how Kimia Farma Persero Tbk’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kimia Farma Persero Tbk - Asset Composition Analysis
Current Asset Composition (December 2024)
Kimia Farma Persero Tbk's total assets of Rp14.97 Trillion consist of 26.3% current assets and 73.7% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp40.37 Billion | 2.9% |
| Accounts Receivable | Rp1.35 Trillion | 9.0% |
| Inventory | Rp1.50 Trillion | 10.1% |
| Property, Plant & Equipment | Rp9.56 Trillion | 63.9% |
| Intangible Assets | Rp57.03 Billion | 0.4% |
| Goodwill | Rp53.68 Billion | 0.4% |
Asset Composition Trend (2002–2024)
This chart illustrates how Kimia Farma Persero Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kimia Farma Persero Tbk's current assets represent 26.3% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2024, down from 11.6% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is property, plant & equipment at 63.9% of total assets.
Kimia Farma Persero Tbk Competitors by Total Assets
Key competitors of Kimia Farma Persero Tbk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Kimia Farma Persero Tbk - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Kimia Farma Persero Tbk generates 0.66x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Kimia Farma Persero Tbk is currently not profitable relative to its asset base.
Kimia Farma Persero Tbk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.61 | 0.89 |
| Quick Ratio | 0.39 | 0.37 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp-2.80 Trillion | Rp -3.52 Trillion | Rp -810.75 Billion |
Kimia Farma Persero Tbk - Advanced Valuation Insights
This section examines the relationship between Kimia Farma Persero Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -14.9% |
| Total Assets | Rp14.97 Trillion |
| Market Capitalization | $16.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kimia Farma Persero Tbk's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Kimia Farma Persero Tbk's assets decreased by 14.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Kimia Farma Persero Tbk (2002–2024)
The table below shows the annual total assets of Kimia Farma Persero Tbk from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp14.97 Trillion | -14.89% |
| 2023-12-31 | Rp17.59 Trillion | -13.60% |
| 2022-12-31 | Rp20.35 Trillion | +14.60% |
| 2021-12-31 | Rp17.76 Trillion | +1.12% |
| 2020-12-31 | Rp17.56 Trillion | -4.30% |
| 2019-12-31 | Rp18.35 Trillion | +94.00% |
| 2018-12-31 | Rp9.46 Trillion | +55.19% |
| 2017-12-31 | Rp6.10 Trillion | +32.16% |
| 2016-12-31 | Rp4.61 Trillion | +42.53% |
| 2015-12-31 | Rp3.24 Trillion | +9.03% |
| 2014-12-31 | Rp2.97 Trillion | +20.08% |
| 2013-12-31 | Rp2.47 Trillion | +19.05% |
| 2012-12-31 | Rp2.08 Trillion | +15.72% |
| 2011-12-31 | Rp1.79 Trillion | +8.26% |
| 2010-12-31 | Rp1.66 Trillion | +6.06% |
| 2009-12-31 | Rp1.56 Trillion | +8.09% |
| 2008-12-31 | Rp1.45 Trillion | +4.25% |
| 2007-12-31 | Rp1.39 Trillion | +9.95% |
| 2006-12-31 | Rp1.26 Trillion | +7.10% |
| 2005-12-31 | Rp1.18 Trillion | +0.35% |
| 2004-12-31 | Rp1.17 Trillion | -14.14% |
| 2003-12-31 | Rp1.37 Trillion | +31.60% |
| 2002-12-31 | Rp1.04 Trillion | -- |